AI is the new mantra in healthcare and is being touted by many as one of the impending saviours of personalising the patient experience, as it is a key component of the much-vaunted Transformation of Self-Care. By others it’s seen as flawed and impractical to adopt, as the quality of data and process collation is driven by the behaviour of the patient and therapy ecosystem they currently live in. This talk looks at lessons learnt from when AI has attempted to digitally transform patient and caregiver behaviour as part of chronic disease self-care. The focus will be on digital medical devices for asthma, allergies and regular medication based on the implementation and pilot testing of real-world AI solutions, which have been key to learning what design-thinking works and does not work when designing AI into a patients life. Attendees will hear what design-thinking approaches were taken, the benefits-and drawbacks of how this impacted factors that make adjustment to chronic medical illness psychologically demanding, and how cross-collaboration worked with business product owners, data scientists, engineers, patients and caregivers. The talk concludes with a summary of challenges, opportunities and future capabilities needed by designers when creating self-care solutions for patients and caregivers, where AI is trusted enough to act on insights.
Founder and CEO, Metaphase Design Group Inc.